Bankrupt Savient Wins Approval For Ch. 11 Plan
A Delaware bankruptcy judge on Monday blessed Savient Pharmaceuticals Inc.'s Chapter 11 liquidation plan, allowing the estate of the former drug developer to distribute $120 million in sale proceeds and other...To view the full article, register now.
Already a subscriber? Click here to view full article